Zach Scheiner, PhD

Zach Scheiner is a Principal on the Investment Team at RA Capital Management. Zach works on both public and private investments and serves as a Board Director for Exo Imaging, LENZ Therapeutics, Nkarta Therapeutics, SpyGlass Pharma, and Sydnexis. Previously, Zach covered the neurology, ophthalmology, and dermatology landscapes. Zach holds a BS in Molecular Biophysics and Biochemistry from Yale University, and a PhD in Neurobiology and Behavior from the University of Washington. Zach previously worked as a Science Officer at the California Institute for Regenerative Medicine.